510(k) Report

510(k) · Cleared

Cleared

TRAQinform IQ

K233998510(k) TraditionalCleared Sep 5, 2024262-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aiq Global, Inc. · LLZ System, Image Processing, Radiological

Cleared on Sep 5, 2024 as substantially equivalent to K173444 (Aiq Solutions, Inc., 2018) after a 262-day review. Its family tree reaches back 9 generations to 1995.

Decided
Sep 5, 2024
Review
262 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K950279 (1995). 40 ancestors in all, the oldest K913475 (1991). No later device cites it as a predicate yet.

  1. Root · 9 generations backK950279 TOMTECP90Tomtec Imaging Systems, Inc. · 1995
  2. 5 generations between
  3. 3 generations backK111319 Ibis Explorer and Markup SoftwareMedqia · 2011
  4. 2 generations backK122205 EXINIExini Diagnostics AB · 2012
  5. 1 generation backK173444 Quantitative Total Extensible Imaging (QTxI)Aiq Solutions, Inc. · 2018
  6. This deviceK233998 TRAQinform IQAiq Global, Inc. · 2024
Show all 9 generations
  1. Root · 9 generations backK950279 TOMTECP90Tomtec Imaging Systems, Inc. · 1995
  2. 8 generations backK964803 Univision Echocardiology SystemNetwork Concepts, Inc. · 1997
  3. 7 generations backK980060 EcholinkMpacs, LLC · 1998
  4. 6 generations backK992259 Echocardiography System Series 95000Camtronics, Ltd. · 1999
  5. 5 generations backK041029 KinetdxSiemens Medi Cal Solutions, Inc. · 2004 · Recalled
  6. 4 generations backK053133 Syngo Dynamics, Version 5.0Siemens Medical Solutions USA, Inc. · 2005 · Recalled
  7. 3 generations backK111319 Ibis Explorer and Markup SoftwareMedqia · 2011
  8. 2 generations backK122205 EXINIExini Diagnostics AB · 2012
  9. 1 generation backK173444 Quantitative Total Extensible Imaging (QTxI)Aiq Solutions, Inc. · 2018
  10. This deviceK233998 TRAQinform IQAiq Global, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K950279TOMTECP90Tomtec Imaging Systems, Inc.1995—
−8K964803Univision Echocardiology SystemNetwork Concepts, Inc.1997—
−7K980060EcholinkMpacs, LLC1998—
−6K992259Echocardiography System Series 95000Camtronics, Ltd.1999—
−5K041029KinetdxSiemens Medi Cal Solutions, Inc.20041
−4K053133Syngo Dynamics, Version 5.0Siemens Medical Solutions USA, Inc.20052
−3K111319Ibis Explorer and Markup SoftwareMedqia2011—
−2K122205EXINIExini Diagnostics AB2012—
−1K173444Quantitative Total Extensible Imaging (QTxI)Aiq Solutions, Inc.2018—
0 (this device)K233998TRAQinform IQAiq Global, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199120
199210
199320
199410
199510
199660
199730
199830
200020
200120
200230
200530
200710
200810
FIG. 1 — Lineage of K233998, 1995–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173444Quantitative Total Extensible Imaging (QTxI)
Summary page 7
…re Archiving and Communications System Product Code: LLZ Regulatory Class: Class II Classification Panel: Radiology Predicate Device Name of Device: QTxI 510(k) Number: K173444 Regulation No: 21 CFR 892.2050 Product Code: LLZ Regulatory Class: Class II Classification Panel: Radiology Reference Device Nam…
Aiq Solutions, Inc.2018—
†K071964Mim 4.1 (Seastar)Mimvista Corp.20072

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 10 companies; a new generation was cleared every 1.5 years on median.
  • 8 of the 40 ancestors have a recall of any class.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

TRAQinform IQ is a software only device that provides a quantitative TRAQinform Report on lesions identified as Regions of Interest (ROI) in PET/CT DICOM compliant imaging data acquired, interpreted, and reported on per local practice prior to device use. Clinicians responsible for patient care and for ordering TRAQinform Reports as an adjunct to locally reported image interpretation do not interact directly with the device. Clinicians responsible for…

Read the full statement (468 words)

TRAQinform IQ is a software only device that provides a quantitative TRAQinform Report on lesions identified as Regions of Interest (ROI) in PET/CT DICOM compliant imaging data acquired, interpreted, and reported on per local practice prior to device use.

Clinicians responsible for patient care and for ordering TRAQinform Reports as an adjunct to locally reported image interpretation do not interact directly with the device. Clinicians responsible for local image interpretation do not interact with the device and generate their reporting before and independently of the TRAQinform Report.

The TRAQinform Report is generated by the device manufacturer and signed by a U.S. board certified physician responsible for supervising central report generation and qualified to practice nuclear radiology/medicine. The TRAQinform Report is for use by trained medical professionals including but not limited to oncologists, nuclear radiologists/physicians, medical imaging technologists, dosimetrists, and physicists.

TRAQinform IQ software contains the following functionalities:

• Automated matching of ROI between previously performed CT and PET/CT DICOM 3.0 volumetric medical images.

• In order to perform automated matching of ROI and quantitative analysis of previously performed CT and PET/CT DICOM 3.0 volumetric medical images, the software initially performs the following functions:

▪ Machine learning skeletal and anatomic structure segmentation.

▪ Threshold-based ROI identification and contouring.

• Automated quantitative analysis to assess previously performed CT and PET/CT DICOM 3.0 volumetric medical images, including: change in total volume and density of each identified ROI, and change in Fludeoxyglucose F18 (FDG) tracer uptake of each identified ROI among images.

• Generation of images of the anatomy combined with spatial and quantitative information, including computed classification of quantitative FDG ROI changes.

For multi-timepoint quantitative analysis, recommended use is in adult patients 22 years and older with partial or whole-body PET/CT acquired following administration of FDG per approved drug prescribing information and with the second FDG administration separated from the first by a period not to exceed 12 months.

For single-timepoint quantitative analysis, recommended use is in adult patients 22 years and older with partial or whole-body PET/CT following administration of FDG, a PSMA targeted PET drug, or a SSTR-targeted PET drug per approved drug prescribing information.

Discrepancies between TRAQinform IQ and local PET/CT reporting have been investigated and use of TRAQinform IQ has not been established for binary patient level progression or non-progression decisions without multidisciplinary review. Discrepancies between TRAQinform IQ and local PET/CT reporting that could impact patient care should therefore prompt consultation with subject matter experts (for example, in tumor board), with a patient-centered focus on discrepant imaging regions and with blinded or otherwise neutral adjudication regarding interpretation/classification source.

TRAQinform IQ is not intended to diagnose any disease, replace the diagnostic procedures for interpretation of CT or PET/CT images, recommend any specific treatment, nor is it intended to replace the skill and judgment of a qualified medical professional.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233998: TRAQinform IQ.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233998

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026